Marc Schegerin
Director of Finance/CFO at MORPHIC HOLDING, INC.
Net worth: 1 M $ as of 29/04/2024
Marc Schegerin active positions
Companies | Position | Start | End |
---|---|---|---|
MORPHIC HOLDING, INC. | Chief Operating Officer | 05/04/2020 | - |
Director of Finance/CFO | 05/04/2020 | - | |
SQZ BIOTECHNOLOGIES COMPANY | Director/Board Member | 22/10/2020 | - |
Independent Dir/Board Member | 22/10/2020 | - | |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Chief Operating Officer | 31/03/2020 | - |
Director of Finance/CFO | 31/03/2020 | - |
Career history of Marc Schegerin
Former positions of Marc Schegerin
Companies | Position | Start | End |
---|---|---|---|
ARQULE, INC. | Director of Finance/CFO | 28/03/2019 | 31/12/2019 |
Public Communications Contact | 23/05/2018 | 28/03/2019 | |
CITIGROUP INC. | Director/Board Member | 31/05/2016 | 31/03/2018 |
SAGE THERAPEUTICS, INC. | Director/Board Member | 31/12/2012 | 31/12/2013 |
BIOGEN INC. | Corporate Officer/Principal | 31/12/2008 | 31/12/2012 |
Training of Marc Schegerin
Dartmouth Medical School | Doctorate Degree |
Tuck School of Business at Dartmouth | Masters Business Admin |
Tulane University (Louisiana) | Undergraduate Degree |
Harvard University | Undergraduate Degree |
Statistics
International
United States | 12 |
Operational
Director/Board Member | 3 |
Director of Finance/CFO | 3 |
Chief Operating Officer | 2 |
Sectoral
Health Technology | 7 |
Consumer Services | 5 |
Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 5 |
---|---|
MORPHIC HOLDING, INC. | Health Technology |
SQZ BIOTECHNOLOGIES COMPANY | Health Technology |
CITIGROUP INC. | Finance |
BIOGEN INC. | Health Technology |
SAGE THERAPEUTICS, INC. | Health Technology |
Private companies | 2 |
---|---|
ArQule, Inc.
ArQule, Inc. Pharmaceuticals: MajorHealth Technology ArQule, Inc. is a biopharmaceutical company, which engages in the research and development of therapeutics to treat cancers and rare diseases. The company was founded in 1993 and is headquartered in Burlington, MA. | Health Technology |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Health Technology |
- Stock Market
- Insiders
- Marc Schegerin
- Experience